Natural Resources >> CEO Interviews >> January 22, 2021
Interview with the President and CEO: Yield10 Bioscience, Inc. (NASDAQ:YTEN)
Oliver P. Peoples, Ph.D., was named President and Chief Executive Officer of Metabolix in October 2016 in conjunction with the transition to Yield10 Bioscience as the company’s core business. Dr. Peoples was a co-founder of Metabolix and served as Chief Scientific Officer from January 2000 until October 2016, and was previously Vice President of Research and Development. Dr. Peoples has served as a director since June 1992. Prior to founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at the Massachusetts Institute of Technology where he emerged as a pioneer of the new field of metabolic pathway engineering and its applications in industrial biotechnology. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce Mirel biopolymers. Dr. Peoples has published numerous peer-reviewed academic papers and is an inventor of over 90 patents and patent applications worldwide. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland. Profile
Word count: 3,541
TWST: Could you tell me about the company?
Dr. Peoples: Yes. We’re essentially an ag-biotechnology company, formed back in January 2017. Our